What’s Vulnerable › Vulnerabilities

CVE-2022-26239

• Severity: medium (CVSS 5.5 v3.1)
• Exploited in the wild: not listed in CISA KEV
• EPSS: 0.2% probability of exploitation in the next 30 days
• Public exploit or detection template: none known
• Published: 2022-10-06 · updated 2026-06-17
• Weakness: CWE-732

Description

The default privileges for the running service Normand License Manager in Beckman Coulter Remisol Advance v2.0.12.1 and prior allows unprivileged users to overwrite and manipulate executables and libraries. This allows attackers to access sensitive data.

Affected products

• Beckmancoulter Remisol Advance: through 2.0.12.1

References

• https://pastebin.com/1QEHrj01
• https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advance
• https://pastebin.com/1QEHrj01
• https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advance

Get alerted when CVE-2022-26239 or the next vulnerability affects your stack